Xenbase Image ID: 81510

Fig. 3. Marker analysis with VPA treatment. Embryos were treated with buffer control (A,C,E,G, I, K, M,O,Q,S,U,W, Y, AA) or VPA during stage 102 (B,D,F,H,J,L,N,P,R,T,V,X, Z, BB). Whole mount in situ hybridization performed for the indicated markers shows no change in expression with VPA treatment. myod (A,B), vent2 (C,D), nkx2.5 (G,H), xrx1 (I,J), xbra (K,L), slug (Q,R), tbx20 (S,T), otx2 (U,V), ventral view. xpo (E,F), lim (W,X), krox20 (O,P) lateral view, anterior to the left, hoxb9 (M,N); dorsal view, anterior to the left. Also unaffected by VPA treatment were VBI-derived mye- loid marker mpo (Y, Z) and vascular marker aplnr (AA, BB), lateral view, anterior to the right. myod, vent2, xpo, xbra: late gastrula. nkx2.5, xrx1, slug, hoxb9: neurula stages. lim1, krox20, mpo, aplnr, tbx20, otx2: tailbud stages. Image published in: Shah RR et al. (2013) Copyright © 2013. Image reproduced with permission of the Publisher, John Wiley & Sons. Larger Image Printer Friendly View

Return to previous page